Kotaku
Quartz
The Root
The Inventory
Search
Free Newsletters
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
Editions
Español
Deutsch
Français
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
About
Editions
Español
Deutsch
Français
Explore our other sites
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
GOOGL
+2.38%
$206.01
+$4.78
FDS
-0.23%
$468.72
-$1.09
AMZN
+1.90%
$241.93
+$4.51
NVDA
+1.73%
$118.68
+$2.02
TSLA
+2.18%
$392.06
+$8.38
PLTR
+23.17%
$103.14
+$19.40
ILMN
-6.18%
$123.00
-$8.10
PVH
-1.00%
$82.49
-$0.83
HIMS
+7.01%
$41.66
+$2.73
NVS
-0.04%
$105.44
-$0.05
GOOGL
+2.38%
$206.01
+$4.78
FDS
-0.23%
$468.72
-$1.09
AMZN
+1.90%
$241.93
+$4.51
NVDA
+1.73%
$118.68
+$2.02
TSLA
+2.18%
$392.06
+$8.38
PLTR
+23.17%
$103.14
+$19.40
ILMN
-6.18%
$123.00
-$8.10
PVH
-1.00%
$82.49
-$0.83
HIMS
+7.01%
$41.66
+$2.73
NVS
-0.04%
$105.44
-$0.05
Markets
RECENT NEWS
The FDA approved a new non-opioid painkiller. Its maker's stock is rising
Friday 8:30AM
Septerna Inc. (SEPN) reports earnings
November 20, 2024
A non-opioid pain med, a COVID-flu shot combo, and more: 7 drug launches to watch in 2025
October 25, 2024
Advertisement